US Business
Older Shoppers Are the Hot New Thing for Consumer Brands
Demographic changes and the pandemic are prompting companies to launch new products aimed at consumers they say are increasingly interested in aging well.
Articles by Erin Slifka
US Business
The Real Force Driving the GameStop Revolution
Individual traders banded together this past week to move markets like never before. But the build-up to this remarkable moment has been happening for decades.
US Business
Elon Musk Fuels Market Turmoil in Renewed Battle Against Short Sellers
Tesla’s CEO has been sparring with Wall Street bears for years, so it’s hardly surprising that he has again turned to Twitter to get in jabs during the GameStop rumble.
US Business
J&J Covid-19 Vaccine Was 66% Effective in Late-Stage Study
Johnson & Johnson, one of the world’s biggest health-care companies, said it would ask American regulators in early February to authorize use.
US Business
How Apple’s Privacy Change Will Hit Facebook’s Core Ad Business
Apple’s new feature will limit Facebook’s ability to collect data from apps—information that allows its advertisers to target their ads efficiently.
Chamber Updates
Tomorrow’s Leaders Today 2021 Opening Session
Tomorrow’s Leaders Today (TLT) held the opening retreat on January 13. The class of 43 area high school seniors had the opportunity to meet with Joplin leaders in a round table setting. They were also […]
US Business
Insiders at GameStop, BlackBerry, LaCroix Maker Sit on Big Stock Gains
The recent Reddit-fueled trading in long-struggling companies has boosted the holdings of CEOs and directors, though few have reported cashing in.
US Business
McKinsey Is in Settlement Talks With States Over Opioid Work
The talks come amid the release of court filings in recent months detailing recommendations the consulting firm made to Purdue Pharma on how to aggressively boost sales of its OxyContin painkiller.
US Business
Mondelez Says Its Snacks Gained Share During Pandemic
The maker of Oreos and Triscuits booked higher sales and profit in the latest quarter.
US Business
Behind AstraZeneca’s Covid-19 Vaccine Stumble
AstraZeneca’s CEO promised more shots, at a lower price, than competitors, but now faces criticism from the EU for a production shortfall.